These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32852080)

  • 21. Prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae IgM and IgG antibodies in Tunisian patients presenting with exacerbation of chronic obstructive pulmonary disease.
    Messous S; Trabelsi I; Grissa MH; Nouira S; Pozzetto B; Mastouri M
    Med Mal Infect; 2017 Mar; 47(2):158-163. PubMed ID: 28062246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology.
    Martínez MA; Ruiz M; Zunino E; Luchsinger V; Avendaño LF
    J Med Microbiol; 2008 Dec; 57(Pt 12):1491-1495. PubMed ID: 19018018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies.
    Kuwahara M; Samukawa M; Ikeda T; Morikawa M; Ueno R; Hamada Y; Kusunoki S
    J Neurol; 2017 Mar; 264(3):467-475. PubMed ID: 28025664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Serologic Diagnosis of Mycoplasma pneumoniae Pneumonia: An Observational Study on Changes in Titers of Specific-IgM Antibodies and Cold Agglutinins.
    Lee SC; Youn YS; Rhim JW; Kang JH; Lee KY
    Medicine (Baltimore); 2016 May; 95(19):e3605. PubMed ID: 27175666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad.
    Nagalingam NA; Adesiyun AA; Swanston WH; Bartholomew M
    New Microbiol; 2004 Oct; 27(4):345-51. PubMed ID: 15646048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of immunoglobulin M and immunoglobulin G antibodies to Mycoplasma pneumoniae in children with community-acquired lower respiratory tract infections.
    Kumar S; Garg IB; Sethi GR; Kumar S; Saigal SR
    Indian J Pathol Microbiol; 2018; 61(2):214-218. PubMed ID: 29676360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Nucleic Acid Amplification and IgM Tests for the Diagnosis of Mycoplasma pneumoniae Infection in Children During a Recent Korean Outbreak.
    Lee HY; Sul S; Lee JY; Kim MN; Yu J; Sung H
    Lab Med; 2021 Mar; 52(2):181-187. PubMed ID: 32882711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance.
    Ma YJ; Wang SM; Cho YH; Shen CF; Liu CC; Chi H; Huang YC; Huang LM; Huang YC; Lin HC; Ho YH; Mu JJ;
    J Microbiol Immunol Infect; 2015 Dec; 48(6):632-8. PubMed ID: 25311405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".
    Beersma MF; Dirven K; van Dam AP; Templeton KE; Claas EC; Goossens H
    J Clin Microbiol; 2005 May; 43(5):2277-85. PubMed ID: 15872256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of mycoplasma pneumoniae infection in aetiopathogenesis of juvenile idiopatic arthritis].
    Postepski J; Opoka-Winiarska V; Kozioł-Montewka M; Korobowicz A; Tuszkiewicz-Misztal E
    Med Wieku Rozwoj; 2003; 7(2):271-7. PubMed ID: 12878798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological Study on
    Cai F; Shou X; Ye Q
    Front Cell Infect Microbiol; 2022; 12():843463. PubMed ID: 35386684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory diagnosis of Mycoplasma pneumoniae infection. 3. Detection of IgM antibodies to M. pneumoniae by a modified indirect haemagglutination test.
    Kok TW; Marmion BP; Varkanis G; Worswick DA; Martin J
    Epidemiol Infect; 1989 Dec; 103(3):613-23. PubMed ID: 2514114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Mycoplasma pneumoniae and asthma among Indian children.
    Varshney AK; Chaudhry R; Saharan S; Kabra SK; Dhawan B; Dar L; Malhotra P
    FEMS Immunol Med Microbiol; 2009 Jun; 56(1):25-31. PubMed ID: 19239491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Mycoplasma pneumoniae Infection in Malagasy Children.
    Ravelomanana L; Bouazza N; Rakotomahefa M; Andrianirina AZ; Robinson AL; Raobidjaona H; Andriamihaja R; Benhaddou N; Randrianirina F; Ratsima E; Imbert P; Raymond J
    Pediatr Infect Dis J; 2017 May; 36(5):467-471. PubMed ID: 28403048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial.
    Alexander TS; Gray LD; Kraft JA; Leland DS; Nikaido MT; Willis DH
    J Clin Microbiol; 1996 May; 34(5):1180-3. PubMed ID: 8727899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycoplasma pneumoniae in Children With and Without Community-acquired Pneumonia. What do PCR and Serology Say?
    Copete AR; Vera C; Herrera M; Aguilar YA; Rueda ZV; Vélez LA
    Pediatr Infect Dis J; 2020 Jul; 39(7):e104-e108. PubMed ID: 32118860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and mycoplasma pneumoniae coinfection.
    Fan BE; Lim KGE; Chong VCL; Chan SSW; Ong KH; Kuperan P
    Am J Hematol; 2020 Jun; 95(6):723-724. PubMed ID: 32173883
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease.
    Varma-Basil M; Dwivedi SKD; Kumar K; Pathak R; Rastogi R; Thukral SS; Shariff M; Vijayan VK; Chhabra SK; Chaudhary R
    J Med Microbiol; 2009 Mar; 58(Pt 3):322-326. PubMed ID: 19208881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of
    Kim JH; Kwon JH; Lee JY; Lee JS; Ryu JM; Kim SH; Lim KS; Kim WY
    J Thorac Dis; 2018 Nov; 10(11):6118-6127. PubMed ID: 30622783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic values of a combination of intervals between respiratory illness and onset of neurological symptoms and elevated serum IgM titers in Mycoplasma pneumoniae encephalopathy.
    Hu CF; Wang CC; Chen SJ; Perng CL; Yang HY; Fan HC
    J Microbiol Immunol Infect; 2014 Dec; 47(6):497-502. PubMed ID: 23968755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.